Digital health platform Ayble Health partnered with Mayo Clinic to offer patients a hybrid care model for digestive health that matches them with the appropriate virtual and in-person services based on their acuity and needs. The hybrid care model is available for large employers and health plans.
Oshi Health recently entered a value-based care contract with Aetna. The New York-based startup provides specialized virtual care for patients with digestive disorders, focusing on dietary and behavioral health interventions to reduce the root cause of patients' symptoms.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company's lead product Regulora delivers a standardized 12-week therapy which bring patients into a state of deep relaxation and suggestibility before using metaphors and stories to create a sense of comfort and ease around the individual's condition and symptoms.
The Silicon Valley startup has developed a cloud-based platform for recording colonoscopies. It allows gastroenterologists to start and stop recording the procedure with the push of a button.
Chicago-based gastroenterologist Larry Kosinski of the Illinois Gastroenterology Group is excited by the prospects for SonarMD, the population health company he founded and for which he serves as Chief Medical Officer.
Investors have backed a company making disposable devices for minimally invasive gastroenterology procedures with a new $3 million in capital, according to a U.S. Securities and Exchange Commission filing. SafeStitch Medical’s (OTCBB:SFES) private placement came from 17 investors, according to the filing. A company representative did not reply to a request for details, but it […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A 7-year-old pharmaceutical company that’s developed a new way to create and deliver an old kind of drug is making the critical transition to the clinical stage as it prepares to take its drug for Crohn’s disease and ulcerative colitis into human trials. The U.S. Food and Drug Administration has cleared the IND application filed […]
A promising new combination drug for ulcerative colitis treatment is looking for investments to carry it through a phase 2 efficacy trial this year. Altheus Therapeutics Inc.’s candidate, Zoenasa, combines the anti-inflammatory drug mesalamine, which is already approved and commonly used to treat the condition, with a powerful antioxidant to reduce bowel injury in inflammatory […]
Salix Pharmaceuticals (NASDAQ:SLXP) believes that there’s enough solid data available now to warrant U.S. Food and Drug Administration approval of its new irritable bowel syndrome drug and at a meeting with the agency next month, the company will ask regulators to approve it. If the FDA wants more work done on the drug, Salix CEO […]
Salix Pharmaceuticals is extending an agreement with an Indian pharmaceutical partner to give Salix exclusive global rights, except for India, to a key drug-delivery technology. Morrisville, North Carolina-based Salix (NASDAQ:SLXP) in 2009 licensed the drug delivery technology from Mumbai, India-based Lupin Pharmaceuticals. Salix uses that technology in its gastrointestinal drug rifaximin, marketed as Xifaxan. Salix […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The U. S. Food and Drug Administration has signaled it will not approve an irritable bowel syndrome treatment being developed by Morrisville, North Carolina-based Salix Pharmaceuticals. Salix says it won't know more details until it formally receives a complete response letter from the FDA.
NinePoint Medical Inc. signs a licensing deal with Mass. General Hospital for 188 of the institution’s patents and patent applications. NinePoint Medical Inc. entered into a licensing deal with Mass. General Hospital for 188 patents and patent applications owned by the institution. The Cambridge, Mass.-based company plans to incorporate the intellectual property into its high-resolution […]
The life of a general surgeon is one fraught with contingency, soul-crushing doubt, unexpected disaster, and overwhelming stress. We wade into shark infested waters every time we press scalpel into flesh. Your eyes better be wide open and your head on a swivel. There's no such thing as routine in general surgery
Torax Medical Inc. has received regulatory approval from the European Union to sell an implantable device that treats patients suffering from acid reflux disease. The company’s Linx device is intended for patients with gastroesophageal reflux disease, which involves stomach juices flowing upward into the esophagus. The disease is caused by defects to the esophageal sphincter […]
MAX Endoscopy Inc. in Macedonia, Ohio, has received a $250,000 investment commitment from JumpStart Inc., the venture development organization in Cleveland. MAX Endoscopy will use the money to formalize sales and marketing efforts for its fiber-optic technology that is used with endoscopes to treat hemorrhoids.